Doctors across Europe writing prescriptions for mail-order marijuana. The online cannabis sale revolution has transformed Germany’s drug market in just two years. Lukas, a 20-year-old living outside Berlin, used to wander through parks at night to buy marijuana. He arranged illicit street pickups. Now he needs just five minutes and an internet connection. Germany liberalised its cannabis laws two years ago. Since then, platforms like Cannadoc24 and Weed.de have become the go-to method for accessing legal cannabis. The digital marijuana market has exploded beyond anyone’s expectations.

Cannabis is Germany’s newest multi-billion-euro industry. Moreover, medical cannabis imports rocketed to 192 tonnes in 2025. That’s up from just 32 tonnes in 2023. Meanwhile, sales jumped from nearly €1 billion in 2024 to roughly €2 billion in 2025, according to BPC, a business association representing pharmaceutical cannabinoid companies. Furthermore, online pharmacies sit at the heart of this boom. They present customers with marijuana menus worthy of Amsterdam. As a result, the traditional cannabis black market is facing unprecedented competition.

Online Cannabis Sale System Raises Abuse Concerns

Cannabis users can now acquire their supplies with remarkable ease. Consequently, officials worry about potential abuse. Health Minister Nina Warken views the system as urgently requiring tighter restrictions. However, the industry has no interest in seeing runaway revenue vanish.

Last October, Warken introduced legislation requiring in-person doctors’ visits for marijuana prescriptions. Additionally, the proposal would limit fulfilment to brick-and-mortar pharmacies. Nevertheless, the industry quickly lobbied against it. They argue this would harm patients and force many towards illegal alternatives.

“If this law were enacted in its current form, the cannabis industry would collapse by half,” said David Henn, chief executive of Cannamedical Pharma GmbH. According to industry estimates, approximately 40% of current customers would return to black market sources if online access were restricted.

Rural Access Creates Political Divide

Some lawmakers worry the proposed measures could disadvantage genuinely ill patients in rural areas. In particular, doctors can be harder to find in these locations. Therefore, the current digital marijuana market has made access easier for those living outside major cities.

“Telemedicine is a natural part of modern healthcare,” said Matthias Mieves, head of cannabis legislation for the Social Democrats. His votes are required to pass the proposal. “Not every small village has the infrastructure needed.”

Consequently, governing coalition members will continue discussions to reach a compromise. They return from break at the end of February.

The Original Intent: Combating the Black Market

Germany decriminalised cannabis consumption in 2024 to combat the black market. Specifically, the new rules allow users to grow small quantities of their own plants or join membership-based clubs with permission to grow. However, the latter option failed to gain traction. Furthermore, the federal agency granting licences for experimental marijuana shops has yet to approve any.

In contrast, a separate piece of legislation proved far more successful. It removed cannabis from a list of banned narcotics. As a result, doctors can prescribe it more easily than before.

How Online Cannabis Sale Platforms Actually Operate

Within months, dozens of digital platforms began doing brisk business. Specifically, Weed.de, Bloomwell, and DrAnsay led the charge. Meanwhile, online pharmacies such as HiGreen complemented them. Many simply require customers to fill out brief questionnaires about their medical needs. For instance, Lukas stated he was seeking treatment for a ‘sleep disorder’. Subsequently, these questionnaires go for remote review to doctors anywhere in the EU, sometimes as far away as Malta or Croatia.

Once doctors write the prescription, patients can access an online marketplace. Hundreds of pharmacies offer cannabis flowers starting at just over €3 per gramme. In fact, the entire process takes less time than ordering a pizza.

“Within five minutes, I could order 100 grammes to be delivered to my home,” said Lukas, who admits he has no trouble sleeping. “I would say it’s a good thing because you get better weed that’s much purer” compared to the black market.

Questions About Legitimate Medical Use

Many consumers likely share Lukas’s perspective. Overall cannabis prescriptions have soared. Yet orders paid for by Germany’s universal public health insurance system rose by just 9% in 2024. Notably, the system covers about 90% of the population.

German law permits public insurers to pay for cannabis only as a last resort in serious illnesses. Therefore, the fact that the vast majority pay out of pocket has generated suspicion. Statistics show 91% of online cannabis sale transactions involve private payment rather than insurance coverage. This disconnect between medical necessity and actual usage patterns is striking.

“I think this is mainly leisure use disguised as medical therapy,” said Mathias Luderer, an addiction expert at the University of Frankfurt, at a parliamentary hearing in January. Indeed, his assessment highlights growing concerns about liberal prescription policies enabling recreational use.

Advertising Pushes Legal Boundaries

Cannabis portals advertise their prices openly. This raises red flags. Because public insurance normally covers medical costs, patients in Germany typically don’t know pricing details. In contrast, online platforms put cost front and centre.

On its website, DrAnsay offers cannabis prescriptions starting at €14.20. Similarly, in January, CannaDoc24 promoted a free first prescription, with follow-ups costing €9.95. Such offers test the limits of German law. The country has a longstanding ban on advertising prescription medical treatments.

Even more concerning, some platforms have gone further. Several offered cannabis discounts on Halloween and Christmas. Additionally, one hired a popular German rapper as a marketing spokesperson. These tactics clearly blur the line between medical service and consumer retail.

Digital Marijuana Market Faces Legal Challenges

The Apothekenkammer Nordrhein oversees pharmacies in the Cologne and Düsseldorf area. Recently, this regulatory body started taking legal action against questionable campaigns. In January, it secured a victory. A Hamburg court issued an injunction banning Zazaxpress from offering prescriptions without in-person consultations. Furthermore, the judges told the company to stop promising product availability through a popular food delivery service. Zazaxpress didn’t respond to requests for comment.

In response, Weed.de, DrAnsay, and Bloomwell stated their platforms comply with German law. They maintain prescriptions are only available after individual physician assessments. DrAnsay said its doctors are registered in Germany. Similarly, Bloomwell and Weed.de said their EU-based physicians act independently according to professional regulations.

All three maintain there is no evidence their platforms facilitate large-scale recreational use. Moreover, they argue that blaming telemedicine ignores doctor shortages and the absence of legal retail shops. Cannadoc24 didn’t respond to requests for comment.

Industry Consolidation Ahead

Legal cannabis is less than two years old in Germany. Nevertheless, Ingo Schmidt, an analyst at research firm Montega AG, sees these developments as part of a “coming of age for the industry”. He predicts it will result in “a shakeout in terms of quality.”

Smaller, volume-oriented services may fail. In contrast, “established players with a strong pharmaceutical base and stable supply chains will consolidate their market leadership,” he said. Industry analysts estimate that 30% of current platforms may cease operations within 18 months.

Pharmacies Expanding Despite Regulatory Uncertainty

A small group of pharmacies are racing to capitalise on the boom. At Frankfurt-based Kissel Apotheke, medical cannabis now generates about 80% of revenue. Owner Malte Uhlendorf has moved offices twice to accommodate surging demand. His team has grown from four to about 60 people. They now operate out of a 900-square-metre commercial unit on Frankfurt’s outskirts.

Inside the former office space, workers in their early thirties weigh and pack cannabis for shipping. Pop music thumps from speakers as they work. Many say they prefer cannabis mail-order pharmacies over traditional ones. The relaxed atmosphere and younger colleagues appeal to them. Additionally, the work feels less repetitive than conventional pharmacy roles.

Online Cannabis Sale Growth Continues Despite Uncertainty

Uncertainty surrounds the legislative debate’s outcome. Nevertheless, Uhlendorf recently signed a lease for a fourth pharmacy. It could serve both as a mail-order facility and a walk-in location. He’s also weighing options should a mail-order ban take effect.

The expansion reflects confidence in the market. Industry data shows the online cannabis sale channel accounts for 65% of all medical cannabis transactions in Germany. This represents approximately €1.3 billion in annual revenue. Even with regulatory clouds gathering, investors remain bullish on the sector’s long-term prospects.

“Standing still isn’t an option,” Uhlendorf said. “You have to keep moving, even when you don’t know what’s coming.”

Source: bloomberg